Q2 2025 Management View CEO Christopher S. Boerner highlighted, "Our growth portfolio delivered another strong quarter with sales increasing 17% year-over-year, primarily driven by demand across all ...

More deals are likely coming down the pipeline for Biogen Inc. as the company looks to build out its early-stage pipeline.

Backed by Bain Capital LP, the company has invited investment banks to pitch for roles in arranging the share sale, the ...

Bristol Myers Squibb & Co (NYSE:BMY) reported second-quarter 2025 revenues of $12.27 billion, beating the consensus of $11.31 ...

Lincoln National (LNC) posts strong Q2 2025 results with 32% YoY income growth, record group margins, and strategic capital deployment initiatives.

As we try to work out where private equity fits into Australia’s investment landscape, one of its biggest backers has some ...

President Trump is considering whether to encourage retirement funds to invest in private equity, a financial sector that’s ...

The Marine Biological Laboratory in Woods Hole has received the largest private donation in the organization's 137-year ...

The second quarter of 2025 funding data tells a story of capital concentration, sector rotation and investor discipline. Read more here.

An interview with new Virgin Australia Dave Emerson CEO opened the CAPA Airline Leader Summit Australia Pacific in Cairns ...

SINGAPORE] Asia-Pacific could be the new frontier for biotechnology investment, a report by consulting firm Bain & Company ...

Virgin Australia CEO David Emerson, speaking at the CAPA Airline Leader Summit Australia Pacific, stated (31-Jul-2025) "We did not do the IPO in order to raise capital. We did it to transition owners, ...